Cytokines and weight gain in underweight patients with advanced pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004
Cytokines, bone markers and weight in patients with advanced pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005
Dietary counselling in patients with advanced pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 552s Year: 2003
Post-surgery complications in patients with chronic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006
Difficulties in diagnosis of COPD in patients with advanced peripheral artery disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Impact of body weight on lung volumes in patients with pulmonary diseases Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010
Patients profile and pulmonary rehabilitation in interstitial lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018
Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007
Body composition and pulmonary function in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006
Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019
Angiogenic status in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD Source: Eur Respir J 2005; 26: Suppl. 49, 721s Year: 2005
Pulmonary hemodynamics in patients with advanced COPD Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Pulmonary function evaluation in advanced Parkinson‘s disease Source: Eur Respir J 2006; 28: Suppl. 50, 201s Year: 2006
Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018